As of 2026-06-27, the EV/EBITDA ratio of Gritstone Oncology Inc (GRTS) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GRTS's latest enterprise value is -8.76 mil USD. GRTS's TTM EBITDA according to its financial statements is -124.44 mil USD. Dividing these 2 quantities gives us the above GRTS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.1x - 15.5x | 14.2x |
| Forward P/E multiples | 16.8x - 21.8x | 19.9x |
| Fair Price | (41.19) - (37.95) | (41.71) |
| Upside | -128027.0% - -117949.5% | -129630.2% |
| Date | EV/EBITDA |